NFKB1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Background: Previously, we established gemcitabine (Gem)-resistant pancreatic cancer (PaCa) cell lines and showed that the acquisition of Gem resistance is accompanied by enhanced activation of the inflammatory transcription factor nuclear factor-κB (NF-κB).